Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avanos Medical (AVNS) Short-Term Debt issuances (2020 - 2024)

Avanos Medical (AVNS) has disclosed Short-Term Debt issuances for 5 consecutive years, with $20.0 million as the latest value for Q1 2024.

  • Quarterly Short-Term Debt issuances changed N/A to $20.0 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $20.0 million through Dec 2024, down 63.64% year-over-year, with the annual reading at $20.0 million for FY2024, 63.64% down from the prior year.
  • Short-Term Debt issuances hit $20.0 million in Q1 2024 for Avanos Medical, down from $55.0 million in the prior quarter.
  • In the past five years, Short-Term Debt issuances ranged from a high of $185.0 million in Q4 2020 to a low of $20.0 million in Q3 2021.
  • Historically, Short-Term Debt issuances has averaged $71.7 million across 5 years, with a median of $37.5 million in 2021.